Records containing: Small Cell Lung Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-10-15Phase I/II Study of Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-10-05A Phase 1a/1b Dose Escalation and Expansion Study of Single-agent SC-002 in Subjects With Relapsed or Refractory Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma
-
CLINICAL_TRIALS study record update · 2018-09-20Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 Mutation
-
CLINICAL_TRIALS study record update · 2018-09-20Phase II, Single-arm Study of Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification(SUKSE-D)
-
CLINICAL_TRIALS study record update · 2018-09-06"EXHALE" A Randomized Clinical Trial Comparing the Effects of a 12 Week Supervised Exercise Intervention Versus Usual Care for Advanced Stage Lung Cancer Patients.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-08-29Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer: A Randomized Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2018-07-26Phase 2 Open-Label, Multicenter Clinical Study of the Safety and Efficacy of Intravenous Administration of SNS-595 in Patients With Advanced Small Cell Lung Cancer (SCLC)
-
CLINICAL_TRIALS study record update · 2018-07-17A Randomized, Controlled, Open-label, Single Center, Phase II Study to Evaluate the Efficacy and Safety of NK Cell-based Immunotherapy as Maintenance Therapy for Patients With Small-cell Lung Cancer After First-line Chemotherapy.
-
CLINICAL_TRIALS study record update · 2018-07-02A Phase Ib/II Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
-
CLINICAL_TRIALS study record update · 2018-06-06A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects With Small Cell Lung Cancer or Other Non-Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2018-05-25Pilot Study of the Identification of the Molecular Signatures of Relapse in Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-02-27A Phase-1 Study Evaluating the Safety, Pharmacology and Preliminary Activity of MM-310 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-02-07A Phase I/II Study of Ganetespib in Combination With Doxorubicin in Solid Tumors (Phase I) and Refractory Small Cell Lung Cancer (Safety Dose Expansion, Phase II)
-
CLINICAL_TRIALS study record update · 2018-02-01Retrospective Study of Cases of Small Cell Lung Cancer (SCLC) That Appeared During Treatment of Another Lung Carcinoma With or Without Oncogenic Activation (TransCPC)
-
CLINICAL_TRIALS study record update · 2018-01-31A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-01-18A Phase 1/2 Study to Assess the Safety and Efficacy of Lorvotuzumab Mertansine in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors Including Extensive Stage Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-12-04A Phase 2 Study of LY2523355 in Patients With Extensive-Stage Small-Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-11-09Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
-
CLINICAL_TRIALS study record update · 2017-09-07A Non-randomized, Open-label, Prospective, Single-center Study of Apatinib Mesylate Tablet as Third-line and Later Therapy in Patients With Small Cell Cancer（SCLC）
-
CLINICAL_TRIALS study record update · 2017-08-25A Randomized Phase III Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-08-25A Phase II Study Of BIBF 1120 as Second-line Treatment for Patients With Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-08-10NovoTTFTM-100A System Therapy for Refractory CNS Involved Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2017-07-26Phase II Study of Nab-paclitaxel in Sensitive and Refractory Relapsed Small Cell Lung Cancer (Nabster Study)
-
CLINICAL_TRIALS study record update · 2017-07-18Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer (SCLC) Patients: a Phase I Trial.
-
CLINICAL_TRIALS study record update · 2017-07-17Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer